CXCL16 can promote cell proliferation, invasion and migration by mediating PI3K/AKT/PKB and ERK/MAPK pathway, which plays a key role in the progression of NAFLD, cancer, atherosclerosis, renal fibrosis (176). Here, AKT1 is linked to metabolic dysfunction-associated steatotic liver disease.